Standardized Perioperative Care Protocol for Lumbar Fusion Surgery
Impact of a Standardized Perioperative Care Protocol on Functional and Radiographic Outcomes Following Transforaminal Lumbar Interbody Fusion for Degenerative Spondylolisthesis: A Randomized Controlled Trial
1 other identifier
interventional
382
1 country
1
Brief Summary
This is a prospective, randomized controlled trial to evaluate whether a comprehensive, standardized perioperative care protocol (SPCP) improves functional recovery, radiographic outcomes, and quality of life compared to conventional care in patients undergoing transforaminal lumbar interbody fusion (TLIF) for degenerative lumbar spondylolisthesis. The study aims to demonstrate that a protocol-driven approach can lead to better patient outcomes and increased healthcare efficiency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 29, 2025
CompletedFirst Posted
Study publicly available on registry
August 5, 2025
CompletedAugust 5, 2025
July 1, 2025
5.4 years
July 29, 2025
July 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Oswestry Disability Index (ODI) Score
The change in the ODI score from baseline to 2 years post-surgery. The ODI (version 2.1a) is a patient-reported outcome measure that assesses disability due to low back pain. Scores range from 0 to 100, with lower scores indicating less disability.
Baseline, 2 years
Secondary Outcomes (8)
Change in Japanese Orthopaedic Association (JOA) Score
Baseline, 3 months, 6 months, 1 year, 2 years
Change in Visual Analog Scale (VAS) for Back and Leg Pain
Baseline, 3 months, 6 months, 1 year, 2 years
Change in Short Form-36 (SF-36) Quality of Life Scores
Baseline, 3 months, 6 months, 1 year, 2 years
Radiographic Fusion Rate
1 year, 2 years
Change in Segmental Lordosis
Baseline, 1 year, 2 years
- +3 more secondary outcomes
Study Arms (2)
Experimental: Standardized Perioperative Care Protocol (SPCP) Group
EXPERIMENTALPatients randomized to this group received a multi-modal, standardized protocol that included: comprehensive preoperative education and optimization; standardized intraoperative anesthesia and surgical techniques; and a structured postoperative rehabilitation program featuring multimodal analgesia and goal-directed early mobilization.
Active Comparator: Conventional Care Group
ACTIVE COMPARATORPatients randomized to this group received standard institutional care, which was not protocolized. This typically involved surgeon-preference-based perioperative management, variable timing for mobilization and catheter removal, and discharge based on the attending surgeon's general assessment.
Interventions
A multi-component protocol involving preoperative patient education, nutritional screening, standardized anesthesia, goal-directed fluid therapy, multimodal opioid-sparing analgesia, and a structured physiotherapy-led mobilization schedule starting on postoperative day 1.
Standard, non-protocolized institutional perioperative care, with management decisions based on the discretion of the attending surgeon and care team.
Eligibility Criteria
You may qualify if:
- Symptomatic, single-level (L3-L4, L4-L5, or L5-S1) degenerative spondylolisthesis (Meyerding Grade I or II).
- Failure of at least 6 months of conservative therapy.
- Age between 40 and 75 years.
- Suitable for and scheduled to undergo transforaminal lumbar interbody fusion (TLIF) surgery.
- Provided written informed consent.
You may not qualify if:
- High-grade spondylolisthesis (Grade \> II).
- History of previous lumbar surgery.
- Presence of active spinal infection, tumor, or trauma.
- Severe osteoporosis (T-score \< -3.0).
- Significant medical comorbidities precluding major surgery (ASA physical status \> III).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Third Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
Related Publications (1)
Zhao Y, Wu J, Zhang Z, Wang Y, Li B. Impact of a standardized perioperative care protocol on functional and radiographic outcomes following transforaminal lumbar interbody fusion for degenerative spondylolisthesis: a 2-year randomized controlled trial. Front Surg. 2025 Dec 18;12:1679851. doi: 10.3389/fsurg.2025.1679851. eCollection 2025.
PMID: 41488876DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 29, 2025
First Posted
August 5, 2025
Study Start
January 1, 2018
Primary Completion
June 1, 2023
Study Completion
May 1, 2025
Last Updated
August 5, 2025
Record last verified: 2025-07